DM
DRTX

Deerfield Management’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Deerfield Management’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-275,979
Closed -$2.5M – 137
2013
Q3 		$2.5M Sell
275,979
-476,560
-63% -$3.95M 0.12% 94
2013
Q2 		$5.42M Buy
+752,539
New +$5.52M 0.26% 80

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deerfield Management's DRTX Position: Q4 2013 in Review

Deerfield Management sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2013, closing a stake of 275,979 shares — an estimated $2.5M sold.

Deerfield Management first reported a position in DRTX in Q2 2013 and held it in 2 quarters. The position peaked at $5.42M in Q2 2013. 46 funds tracked by Wall St. Rank hold DRTX as of Q4 2013.

  • Deerfield Management reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Deerfield Management sold 275,979 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2013, an estimated $2.5M.
  • Deerfield Management first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 2 quarters.
  • Deerfield Management's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $5.42M in Q2 2013.
  • 46 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2013.

Based on Deerfield Management's 13F filing for Q4 2013, filed 14 Feb 2014.